Relative Valuation Lab

Implied price gap for AbbVie Inc. vs Amgen Inc.

Live view of SEC fundamentals with peer-based benchmarks and implied valuation gaps.

Implied price

Blend averages both multiples when available.

Current vs implied

Current

$214.35

Implied

$104.33

If AbbVie Inc. traded at Amgen Inc. P/E multiple, the stock price would be $104.33 (vs $214.35).

-51.3% (-$110.02)

Implied from P/E

$104.33

Implied from P/S

$169.27

Implied price calculator

Apply the selected peer multiple to the target fundamentals.

Target company

ABBV

Benchmark peer

AMGN

AbbVie Inc. fundamentals

Current price

$214.35

EPS (TTM)

2.39

Rev / share

31.91

Amgen Inc. multiples

P/E multiple

43.65x

P/S multiple

5.30x

Growth vs value matrix

Bottom-right quadrant is the sweet spot: high growth, low valuation.

EV/Revenue vs growth

Smart diff metrics

Highlight the winner and flag when premiums are justified.

Metric	ABBV	Delta vs AMGN	AMGN	Context
Revenue growth (LTM)	3.7%	80.0% lower	18.6%	Growth lag
Gross margin	70.0%	13.8% higher	61.5%	Pricing power
EBITDA margin	31.4%	4.0% higher	30.2%	Operating leverage
EV/Revenue	7.89x	37.9% higher	5.72x	Multiple premium
P/E	90.69x	107.7% higher	43.65x	Expensive
Net debt / EBITDA	3.5	154.6% higher	1.4	Lower leverage

Football field valuation

See where AbbVie Inc. trades vs valuation ranges.

Peer implied

$105.79 - $169.27

Historical band

$195.08 - $238.43

DCF range

$426.43 - $576.94

Value trap detector

Quality signals that explain why a cheap stock might stay cheap.

Piotroski F-Score

Financial strength (0-9).

AbbVie Inc.5/9

Partial coverage: 8/9 checks

Amgen Inc.5/9

Partial coverage: 8/9 checks

Altman Z-Score

Bankruptcy risk gauge.

AbbVie Inc.: not enough data yet.

Amgen Inc.: not enough data yet.

Enterprise value bridge

Market cap + debt - cash = EV.

Enterprise value$444.2B

Market cap $382.6BDebt $67.1BCash -$5.6B

Risk factor diff (10-K Item 1A)

Unique risks that explain valuation discounts.

SEC text parsing is not configured yet. Connect 10-K text ingestion to compare Item 1A risk factors.

MD&A sentiment pulse

Tracks uncertainty language that often precedes multiple compression.

No MD&A sentiment data found. Enable the filing text analyzer to populate this chart.

ABBV CIK: 1551152

AMGN CIK: 318154

Relative Valuation Lab

Implied price gap for AbbVie Inc. vs Amgen Inc.

Live view of SEC fundamentals with peer-based benchmarks and implied valuation gaps.

Implied price

Blend averages both multiples when available.

Current vs implied

Current

$214.35

Implied

$104.33

If AbbVie Inc. traded at Amgen Inc. P/E multiple, the stock price would be $104.33 (vs $214.35).

-51.3% (-$110.02)

Implied from P/E

$104.33

Implied from P/S

$169.27

Implied price calculator

Apply the selected peer multiple to the target fundamentals.

Target company

ABBV

Benchmark peer

AMGN

AbbVie Inc. fundamentals

Current price

$214.35

EPS (TTM)

2.39

Rev / share

31.91

Amgen Inc. multiples

P/E multiple

43.65x

P/S multiple

5.30x

Growth vs value matrix

Bottom-right quadrant is the sweet spot: high growth, low valuation.

EV/Revenue vs growth

Smart diff metrics

Highlight the winner and flag when premiums are justified.

Metric	ABBV	Delta vs AMGN	AMGN	Context
Revenue growth (LTM)	3.7%	80.0% lower	18.6%	Growth lag
Gross margin	70.0%	13.8% higher	61.5%	Pricing power
EBITDA margin	31.4%	4.0% higher	30.2%	Operating leverage
EV/Revenue	7.89x	37.9% higher	5.72x	Multiple premium
P/E	90.69x	107.7% higher	43.65x	Expensive
Net debt / EBITDA	3.5	154.6% higher	1.4	Lower leverage

Football field valuation

See where AbbVie Inc. trades vs valuation ranges.

Peer implied

$105.79 - $169.27

Historical band

$195.08 - $238.43

DCF range

$426.43 - $576.94

Value trap detector

Quality signals that explain why a cheap stock might stay cheap.

Piotroski F-Score

Financial strength (0-9).

AbbVie Inc.5/9

Partial coverage: 8/9 checks

Amgen Inc.5/9

Partial coverage: 8/9 checks

Altman Z-Score

Bankruptcy risk gauge.

AbbVie Inc.: not enough data yet.

Amgen Inc.: not enough data yet.

Enterprise value bridge

Market cap + debt - cash = EV.

Enterprise value$444.2B

Market cap $382.6BDebt $67.1BCash -$5.6B

Risk factor diff (10-K Item 1A)

Unique risks that explain valuation discounts.

SEC text parsing is not configured yet. Connect 10-K text ingestion to compare Item 1A risk factors.

MD&A sentiment pulse

Tracks uncertainty language that often precedes multiple compression.

No MD&A sentiment data found. Enable the filing text analyzer to populate this chart.

ABBV CIK: 1551152

AMGN CIK: 318154